Vanguard Group Inc Exagen Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Exagen Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 490,944 shares of XGN stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
490,944
Previous 490,944
-0.0%
Holding current value
$2.53 Million
Previous $893,000
69.88%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$7.79 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$4.59 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.79 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.75 Million1.04% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT490KShares$2.52 Million0.01% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $83.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...